FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1930485762> ?p ?o ?g. }

• W1930485762 endingPage "1084" @default.
• W1930485762 startingPage "1080" @default.
• W1930485762 abstract "PURPOSE We report an unexpectedly high incidence of hypersensitivity to etoposide among 45 patients with newly diagnosed Hodgkin's disease treated with vinblastine, etoposide, prednisone, and doxorubicin (VEPA) plus radiation. PATIENTS AND METHODS Twenty-three of 45 patients (51%) had one or more acute hypersensitivity reactions to etoposide administration. The 23 patients were 8 to 18 years of age (median, 15 years); 12 were males. Four patients had experienced prior allergic reactions to antibiotics or intravenous contrast media. RESULTS Hypersensitivity reactions followed the first or second dose of VEPA in most cases. The reactions occurred at a median time of 5 minutes (range, 3 to 120) from the start of the etoposide infusion. Fifteen patients reacted early (within 10 minutes), four midway through the infusion, and four after completion of the infusion. Signs and symptoms included flushing, respiratory problems, changes in blood pressure, and abdominal pain with or without nausea and vomiting. Respiratory problems included dyspnea, chest pain/tightness, bronchospasm, and cyanosis. Symptoms were alleviated by discontinuing the etoposide infusions and administering diphenhydramine and/or hydrocortisone; epinephrine was required to reverse bronchospasm in three cases. All 23 patients recovered without adverse sequelae and were rechallenged with etoposide. Fifteen patients tolerated subsequent etoposide infused at a slower rate, with antihistamine and/or corticosteroid premedication; five had recurrent hypersensitivity despite these measures. Three of these five developed similar symptoms when teniposide was substituted for etoposide. Three patients who had isolated episodes of hypotension on completion of the etoposide infusion successfully received subsequent infusions without premedication or change in infusion rate or concentration. CONCLUSION Despite this unexpectedly high incidence of hypersensitivity among Hodgkin's disease patients treated with etoposide, rechallenge with the drug was successful in 78% of cases." @default.
• W1930485762 created "2016-06-24" @default.
• W1930485762 creator A5002643261 @default.
• W1930485762 creator A5012516505 @default.
• W1930485762 creator A5014963717 @default.
• W1930485762 creator A5025947616 @default.
• W1930485762 creator A5035798322 @default.
• W1930485762 creator A5052034230 @default.
• W1930485762 creator A5057411583 @default.
• W1930485762 creator A5060324380 @default.
• W1930485762 creator A5072375420 @default.
• W1930485762 creator A5085873078 @default.
• W1930485762 date "1993-06-01" @default.
• W1930485762 modified "2023-09-25" @default.
• W1930485762 title "Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease." @default.
• W1930485762 cites W1983722005 @default.
• W1930485762 cites W1998581427 @default.
• W1930485762 cites W2031879106 @default.
• W1930485762 cites W2033692956 @default.
• W1930485762 cites W2038988728 @default.
• W1930485762 cites W2040785900 @default.
• W1930485762 cites W2044544880 @default.
• W1930485762 cites W2046741533 @default.
• W1930485762 cites W2051557049 @default.
• W1930485762 cites W2065376073 @default.
• W1930485762 cites W2077435026 @default.
• W1930485762 cites W2146553883 @default.
• W1930485762 cites W2268221171 @default.
• W1930485762 cites W2286167422 @default.
• W1930485762 cites W2402584779 @default.
• W1930485762 cites W2408920557 @default.
• W1930485762 cites W2414307805 @default.
• W1930485762 cites W2882101985 @default.
• W1930485762 cites W3193497930 @default.
• W1930485762 doi "https://doi.org/10.1200/jco.1993.11.6.1080" @default.
• W1930485762 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8501494" @default.
• W1930485762 hasPublicationYear "1993" @default.
• W1930485762 type Work @default.
• W1930485762 sameAs 1930485762 @default.
• W1930485762 citedByCount "53" @default.
• W1930485762 countsByYear W19304857622012 @default.
• W1930485762 countsByYear W19304857622013 @default.
• W1930485762 countsByYear W19304857622014 @default.
• W1930485762 countsByYear W19304857622016 @default.
• W1930485762 countsByYear W19304857622018 @default.
• W1930485762 countsByYear W19304857622019 @default.
• W1930485762 countsByYear W19304857622020 @default.
• W1930485762 countsByYear W19304857622022 @default.
• W1930485762 crossrefType "journal-article" @default.
• W1930485762 hasAuthorship W1930485762A5002643261 @default.
• W1930485762 hasAuthorship W1930485762A5012516505 @default.
• W1930485762 hasAuthorship W1930485762A5014963717 @default.
• W1930485762 hasAuthorship W1930485762A5025947616 @default.
• W1930485762 hasAuthorship W1930485762A5035798322 @default.
• W1930485762 hasAuthorship W1930485762A5052034230 @default.
• W1930485762 hasAuthorship W1930485762A5057411583 @default.
• W1930485762 hasAuthorship W1930485762A5060324380 @default.
• W1930485762 hasAuthorship W1930485762A5072375420 @default.
• W1930485762 hasAuthorship W1930485762A5085873078 @default.
• W1930485762 hasConcept C1122143 @default.
• W1930485762 hasConcept C126322002 @default.
• W1930485762 hasConcept C141071460 @default.
• W1930485762 hasConcept C2776042228 @default.
• W1930485762 hasConcept C2776694085 @default.
• W1930485762 hasConcept C2778088044 @default.
• W1930485762 hasConcept C2778119113 @default.
• W1930485762 hasConcept C2778300832 @default.
• W1930485762 hasConcept C2781292560 @default.
• W1930485762 hasConcept C42219234 @default.
• W1930485762 hasConcept C71924100 @default.
• W1930485762 hasConceptScore W1930485762C1122143 @default.
• W1930485762 hasConceptScore W1930485762C126322002 @default.
• W1930485762 hasConceptScore W1930485762C141071460 @default.
• W1930485762 hasConceptScore W1930485762C2776042228 @default.
• W1930485762 hasConceptScore W1930485762C2776694085 @default.
• W1930485762 hasConceptScore W1930485762C2778088044 @default.
• W1930485762 hasConceptScore W1930485762C2778119113 @default.
• W1930485762 hasConceptScore W1930485762C2778300832 @default.
• W1930485762 hasConceptScore W1930485762C2781292560 @default.
• W1930485762 hasConceptScore W1930485762C42219234 @default.
• W1930485762 hasConceptScore W1930485762C71924100 @default.
• W1930485762 hasIssue "6" @default.
• W1930485762 hasLocation W19304857621 @default.
• W1930485762 hasLocation W19304857622 @default.
• W1930485762 hasOpenAccess W1930485762 @default.
• W1930485762 hasPrimaryLocation W19304857621 @default.
• W1930485762 hasRelatedWork W1930485762 @default.
• W1930485762 hasRelatedWork W1965717788 @default.
• W1930485762 hasRelatedWork W1999263498 @default.
• W1930485762 hasRelatedWork W2146553883 @default.
• W1930485762 hasRelatedWork W2159791714 @default.
• W1930485762 hasRelatedWork W2402584779 @default.
• W1930485762 hasRelatedWork W2418687335 @default.
• W1930485762 hasRelatedWork W2794968281 @default.
• W1930485762 hasRelatedWork W3012749813 @default.
• W1930485762 hasRelatedWork W3165053483 @default.
• W1930485762 hasVolume "11" @default.
• W1930485762 isParatext "false" @default.

• next